Genvax formulation/CNC-225/anti-CTLA4 inhibitor (Cancure)

N/A

Report date: 2025/01/15 13:54:15
NME

Base Information

Drug NameGenvax formulation/CNC-225/anti-CTLA4 inhibitor (Cancure)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCancure
China Registration ClassN/A

Develop Information

Active CompaniesCancure
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A